In order to define the underlying pathways and mediators leading to the observed effects of S100A8/A9 blockade on coronary circulation, we performed a proteomic analysis of LV extracts by qualitative and relative quantitative mass spectrometry on day 7 post-MI. Here, S100A8 is linked to myocardial infarction.